Last $12.04 USD
Change Today -0.05 / -0.41%
Volume 7.0K
ROKA On Other Exchanges
Symbol
Exchange
NASDAQ GM
Frankfurt
As of 12:29 PM 08/20/14 All times are local (Market data is delayed by at least 15 minutes).

roka bioscience inc (ROKA) Snapshot

Open
$12.25
Previous Close
$12.09
Day High
$12.25
Day Low
$11.64
52 Week High
07/18/14 - $13.00
52 Week Low
07/31/14 - $9.15
Market Cap
212.6M
Average Volume 10 Days
62.8K
EPS TTM
$-56.75
Shares Outstanding
17.7M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for ROKA BIOSCIENCE INC (ROKA)

Related News

No related news articles were found.

roka bioscience inc (ROKA) Related Businessweek News

No Related Businessweek News Found

roka bioscience inc (ROKA) Details

Roka Bioscience, Inc., a molecular diagnostics company, focuses on the development and commercialization of molecular assay technologies for the detection of foodborne pathogens in the United States. It provides Atlas instrument, a fully automated molecular diagnostic testing instrument to reduce labor costs and operator error in high-volume foodborne pathogen testing laboratories. The company also offers atlas detection assays that include tests for Salmonella, Listeria, E. coli O157:H7, Shiga toxin-producing E. coli, and Listeria monocytogenes, as well as related consumable supplies. It serves contract testing labs, food processors, and government agencies. The company was founded in 2009 and is headquartered in Warren, New Jersey.

121 Employees
Last Reported Date: 08/11/14
Founded in 2009

roka bioscience inc (ROKA) Top Compensated Officers

Founder, Chief Executive Officer, President a...
Total Annual Compensation: $457.7K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $296.2K
Senior Vice President and General Manager
Total Annual Compensation: $296.2K
Compensation as of Fiscal Year 2013.

roka bioscience inc (ROKA) Key Developments

Roka Bioscience, Inc. Reports Unaudited Earnings Results for the Second Quarter and Six Months Ended June 30, 2014

Roka Bioscience, Inc. reported unaudited earnings results for the second quarter and six months ended June 30, 2014. Net loss for the second quarter was $7.4 million, or a loss of $11.28 per share, compared with $7.9 million, or a loss of $15.96 per share, for the same period in 2013. Revenues for the quarter ended June 30, 2014 rose 107% to $1.4 million, from $671,000 in the same period in 2013. Loss from operations was $7,000,000 against $7,267,000 a year ago. Loss before income taxes was $7,337,000 against $7,941,000 a year ago. Net loss for the six months ended June 30, 2014 was $15.7 million, or a loss of $24.88 per share, compared with $15.7 million, or a loss of $34.10 per share, for the same period in 2013. Revenues for the six months ended June 30, 2014 rose 137% to $2.2 million, from $937,000 in the same period in 2013. The increased revenue in the quarter and six months resulted from an increase in the number of Atlas(R) instruments placed with commercial customers and increased commercial utilization of the Atlas(R) instruments. Loss from operations was $14,369,000 against 14,926,000 a year ago. Loss before income taxes was $15,699,000 against $15,655,000 a year ago.

Roka Bioscience, Inc. to Report Q2, 2014 Results on Aug 11, 2014

Roka Bioscience, Inc. announced that they will report Q2, 2014 results Pre-Market on Aug 11, 2014

Roka Bioscience, Inc., Q2 2014 Earnings Call, Aug 11, 2014

Roka Bioscience, Inc., Q2 2014 Earnings Call, Aug 11, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ROKA:US $12.04 USD -0.05

ROKA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Bio-Rad Laboratories Inc $120.12 USD -0.67
BioMerieux €77.43 EUR -0.47
Neogen Corp $43.89 USD -0.79
View Industry Companies
 

Industry Analysis

ROKA

Industry Average

Valuation ROKA Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 2.3x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 14.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ROKA BIOSCIENCE INC, please visit www.rokabio.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.